Drug and Medication Industry Market Research Reports, May 2013

Value Of Manufacturers' Total Inventories For Nondurable Goods Industries: Chemical Products: Pharmaceuticals And Medicines

• Industry data
• February 2013

Monthly, From 1992 To 2012
Source: U.S. Department of Commerce: Census Bureau

• Industries : Drug and Medication
• Countries : United States

Export (naics): Pharmaceutical And Medicine Manufacturing

• Industry data
• April 2013

Monthly, From 2005 To 2013
Source: U.S. Department of Labor: Bureau of Labor Statistics

• Industries : Drug and Medication
• Countries : United States

Brazil: Demographic Analysis, 2013

• Country report
• April 2013
• 21 pages

... Industrial health sectors chemical and biotech industries medicines active principles vaccines hemoderivatives biologics diagnostic reagents mechanic, electronic and material industries hospitals out ...

• Industries: Drug and Medication
• Countries: Brazil

Value Of Manufacturers' Total Inventories For Nondurable Goods Industries: Chemical Products: Pharmaceuticals And Medicines

• Industry data
• February 2013

Monthly, From 1992 To 2012
Source: U.S. Department of Commerce: Census Bureau

• Industries : Drug and Medication
• Countries : United States

Value Of Manufacturers' Shipments For Nondurable Goods Industries: Chemical Products: Pharmaceuticals And Medicines

• Industry data
• February 2013

Monthly, From 1992 To 2012
Source: U.S. Department of Commerce: Census Bureau

• Industries : Drug and Medication
• Countries : United States

Import (naics): Pharmaceutical And Medicine Manufacturing

• Industry data
• April 2013

Monthly, From 2005 To 2013
Source: U.S. Department of Labor: Bureau of Labor Statistics

• Industries : Drug and Medication
• Countries : United States

Import (harmonized System): Medicaments (except Vaccines, Band., Pharmaceuticals)

• Industry data
• February 2013

Monthly, From 2001 To 2013
Source: U.S. Department of Labor: Bureau of Labor Statistics

• Industries : Drug and Medication
• Countries : United States

Value Of Manufacturers' Shipments For Nondurable Goods Industries: Chemical Products: Pharmaceuticals And Medicines

• Industry data
• February 2013

Monthly, From 1992 To 2012
Source: U.S. Department of Commerce: Census Bureau

• Industries : Drug and Medication
• Countries : United States

Quality by Design - Company Report for Year 2013

• Company report
• April 2013
• 58 pages

• Industries: Drug and Medication
• Countries: United States

Company Report: Drug and Medication in The United Kingdom and India for Year 2013

• Company report
• April 2013
• 2 pages
• by Corporation

• Industries: Drug and Medication
• Countries: United Kingdom, India

Company Report: Drug and Medication in Germany and North America for Year 2013

• Company report
• April 2013
• 2 pages

• Industries: Drug and Medication
• Countries: Germany, North America, United States

Company Report: Vaccine in Europe for Year 2013

• Company report
• April 2013
• 2 pages

... Hexyontm/hexacima complements sanofi pasteur S product family of acp-ipv (acellular pertussis vaccine, inactivated poliovirus vaccine) combination vaccines. The new 6-in-1 vaccine will be available ...

• Industries: Drug and Medication
• Countries: Europe

Company Report: Anti-inflammatory for Year 2013

• Company report
• April 2013
• 2 pages

• Industries: Drug and Medication

Company Report: Drug and Medication in The United States for Year 2013

• Company report
• April 2013
• 6 pages

... In antiretroviral drugs being led by companies such as gilead. In 2011, hiv drugs accounted for $6.4 Billion gilead S sales and they continue to improve treatment in this area. They also appear to be leading ...

• Industries: Drug and Medication
• Countries: World, United States

Pfizer Inc. - Company Report for Year 2013

• Company report
• April 2013
• 16 pages

... Primarily due to strong volume growth in china, which was partially offset by the timing of government purchases of enbrel and the prevenar franchise in certain emerging markets as well as the transfer ...

• Industries: Drug and Medication
• Countries: United States

Biocon Ltd. - Company Report for Year 2013

• Company report
• April 2013
• 15 pages
• by Corporation

... Decreased from ~50% of the overall statin market to ~40% this year while the atorvastatin market has grown. It is because generic atorvastatin is taking the market share away from the innovator brand ...

• Industries: Drug and Medication
• Countries: India

Biocon Ltd. - Company Report for Year 2013

• Company report
• April 2013
• 15 pages
• by Corporation

... Decreased from ~50% of the overall statin market to ~40% this year while the atorvastatin market has grown. It is because generic atorvastatin is taking the market share away from the innovator brand ...

• Industries: Drug and Medication
• Countries: India

Company Report: Drug and Medication in India for Year 2013

• Company report
• April 2013
• 3 pages
• by Corporation

• Industries: Drug and Medication
• Countries: India

Company Report: Drug for Year 2013

• Company report
• April 2013
• 23 pages

• Industries: Drug and Medication

Company Report: Anti-infective in India for Year 2013

• Company report
• April 2013
• 25 pages
• by Corporation

• Industries: Drug and Medication
• Countries: India

Drug Sector in Nigeria

• Industry report
• May 2013
• 5 pages

• Industries: Drug and Medication
• Countries: Nigeria

The Australian Medicine Industry Brief

• Industry report
• April 2013
• 2 pages

• Industries: Drug and Medication
• Countries: Australia

Drug and Medication Sector in Malaysia

• Industry report
• May 2013
• 37 pages

... Adulterants were found to be therapeutic substances associated with the specific indications of the products such as adulterant for sexual enhancement drugs ( sildenafil, tadalafil ), pain relieving drugs ...

• Industries: Drug and Medication
• Countries: Malaysia

U.S. Drug and Medication Industry : Innovation and Technology Trends

• Industry report
• April 2013
• 28 pages
• by Governmental Agency

• Industries: Drug and Medication
• Countries: United States

The Indian Medicine Sector

• Industry report
• April 2013
• 12 pages

... Raipur, chhattisgarh in collaboration with who, who, new delhi. 30/04/2013 The objectives To document the availability and price of key essential medicines for children in the state ...

• Industries: Drug and Medication
• Countries: India

Vaccine Market in Tanzania

• Industry report
• May 2013
• 11 pages

... Of a polio vaccine what does it take to vaccinate a child against polio This two-minute video from unicef shows us that the journey of a polio vaccine is an incredibly complex process. The menafrivac ctc ...

• Industries: Drug and Medication
• Countries: Tanzania, World

Drug and Medication in India : Innovation and Technology Trends

• Industry report
• April 2013
• 20 pages

• Industries: Drug and Medication
• Countries: India

Drug Industry Analysis in The United States and Canada

• Industry report
• May 2013
• 51 pages

... To production interruptions and diminished capacity Economic choices are made where older, less profitable drugs are eliminated as new generics come to market By year-end 2012, we will see $34b in new ...

• Industries: Drug and Medication
• Countries: United States, Canada

Drug and Medication Market Statistics in The United Kingdom

• Industry report
• April 2013
• 105 pages

... Antiretroviral therapy; ci, confidence interval, efv, efavirenz; ftc, emtricitabine; str, single tablet regimen; tdf, tenofovir disoproxil fumarate. Total costs comprised inpatient days, outpatient and dayward ...

• Industries: Drug and Medication
• Countries: United Kingdom

Drug and Medication Industry Analysis

• Industry report
• April 2013
• 53 pages

... Use internally as part of a monthly cleansing regimen for gi health antibiotic, anti-inflammatory, antibacterial, antifungal, antioxidant, anti-parasitic, antiviral, disinfectant candida cleanse ...

• Industries: Drug and Medication

The Russian Drug and Medication Sector : Key Market Figures

• Industry report
• April 2013
• 14 pages

... And + hydrochlorothiazide tablets 50mg+12,5mg azithromycin azithromycin tablets 250mg,500mg,125mg codelac neo tablets butamirate tablets 50mg new products the following new products are expected to be released ...

• Industries: Drug and Medication
• Countries: Russian Federation

Drug in India : Innovation and Technology Trends

• Industry report
• April 2013
• 13 pages

... The policy framework evolved thus far that are likely to affect the availability of drugs and their prices in the coming years. It also discusses issues such as liberalization of trade, investment ...

• Industries: Drug and Medication
• Countries: India

Drug Sector in Africa

• Industry report
• April 2013
• 15 pages

... Equity of access on paper but weak 1010 20/04/2013 harm reduction as a policy pillar is: Rejected by nigeria; Included in 2012-16 drug master plan of so africa but defined as achieved through treatment ...

• Industries: Drug and Medication
• Countries: South Africa, Africa, Tanzania

Vaccine Market Analysis in The United States

• Industry report
• April 2013
• 129 pages

... B ........................................................................................................ hepatitis b (vaccine) hib ................................................................................... Haemophilus influenzae b (vaccine) hic ...

• Industries: Drug and Medication
• Countries: United States

Drug and Medication : Innovation and Technology Trends

• Industry report
• April 2013
• 12 pages

... Clinical regulatory toxicology phase i clinical phase ii clinical diabetes inflammation oncology (non-cytotoxic) anti-infectives clotting disorders obesity cns nce pipeline nce pipeline tyrosine-tzd, non ...

• Industries: Drug and Medication

Drug and Medication Market Brief

• Industry report
• April 2013
• 18 pages

... Antiosteoporosic drugs - casula m, filippi a, flacco e, gambera m, manzoli l, menditto e, orlando v, piccinelli r, tragni e, catapano a. Assessment and potential determinats of compliance and persistence to anti ...

• Industries: Drug and Medication

U.S. Drug and Medication Business : Innovation and Technology Trends

• Industry report
• April 2013
• 47 pages

... Years is not necessarily less than the increase in life expectancy. Since the lifetime risk of being diagnosed with cancer is about 40%, the 1978-2004 increase in the lagged stock of cancer drugs increased the life ...

• Industries: Drug and Medication
• Countries: United States